More than 90,000 people in the United States tested positive for antibodies linked to alpha-gal syndrome between 2017 and 2022, and new CDC blood-donor data from 2024 and 2025 show that nearly one in three donors in parts of Arkansas and Missouri carry the same marker. Alpha-gal syndrome, or AGS, is a condition triggered by tick bites that can cause severe allergic reactions to red meat, dairy, and other mammalian products, sometimes years after a person has eaten those foods without trouble. The condition is spreading beyond its traditional stronghold in the Southeast, and researchers are still working to pin down how many tick species can set it off.
How a sugar molecule turns beef into a threat
AGS starts with a bite from a tick that introduces a sugar molecule called galactose-alpha-1,3-galactose into the bloodstream. The human immune system, which does not naturally produce alpha-gal, can respond by generating IgE antibodies against it. Those antibodies then react when the person eats mammalian meat or products containing the same sugar. Prospective research in the allergy literature documented large post–tick-bite increases in IgE specific to alpha-gal, establishing the direct link between tick exposure and sensitization to mammalian products.
What makes AGS especially hard to diagnose is timing. Allergic reactions typically appear at least two hours after eating, far longer than the near-instant response most food allergies produce. A person who has eaten hamburgers for decades can suddenly develop hives, gastrointestinal distress, or anaphylaxis after a single tick bite primes the immune system. The formal surveillance case definition adopted through the Council of State and Territorial Epidemiologists requires both delayed-onset clinical symptoms and laboratory confirmation of IgE antibodies to alpha-gal associated with a compatible tick bite history.
The scientific trail that led to AGS recognition began with an unexpected pattern in cancer treatment. Researchers found that severe first-dose hypersensitivity reactions to the drug cetuximab were concentrated in the southeastern United States and tied to pre-existing IgE antibodies against alpha-gal. That geographic clustering matched the range of the lone star tick, and the connection between tick bites and red-meat allergy soon followed, reframing what had seemed like a rare drug reaction as a signal of a much broader environmental exposure.
Positive tests jumped 41 percent in four years
A CDC epidemiologic analysis of commercial alpha-gal IgE testing data tracked 357,119 tests from 295,400 individuals between January 2017 and December 2022. Of those, 90,018 people returned positive results. The annual count of positive tests climbed from 13,371 in 2017 to 18,885 in 2021, a roughly 41 percent increase over four years, according to the agency’s Morbidity and Mortality Weekly Report on suspected AGS cases. Although testing volume and clinician awareness also rose during that period, the trend suggests that sensitization to alpha-gal is becoming more common, not merely more frequently recognized.
A separate CDC seroprevalence study, using 3,000 residual blood-donor serum samples collected between November 14, 2024, and April 9, 2025, across 10 states, offered the first population-level snapshot of how widespread alpha-gal sensitization has become. Arkansas recorded the highest estimated seroprevalence at 31.2%, followed by Missouri at 26.0%, both states within the core range of the lone star tick. Those figures reflect sensitization, not necessarily symptomatic AGS, but they signal that the pool of people at risk is far larger than clinical case counts alone suggest and that many individuals may be unaware of their vulnerability.
The geographic footprint is also widening. A CDC peer-reviewed case report in Emerging Infectious Diseases documented new onset of AGS after tick bites in Washington state, well outside the historically emphasized southeastern range. That finding raises the possibility that tick species other than the lone star tick can trigger the same immune response, though the exact mechanism in the Pacific Northwest has not been confirmed. It also underscores that clinicians in non-endemic regions cannot safely dismiss AGS as a purely southern or rural concern.
Gaps in diagnosis, geography, and species identification
Several questions remain open. The CDC’s testing analysis noted that the 90,018 positive results likely represent a fraction of actual cases, because many clinicians are still unfamiliar with AGS and may not order the correct blood test. Patients whose reactions occur hours after a meal often receive misdiagnoses ranging from food poisoning to anxiety before anyone considers an allergic mechanism tied to a tick bite. For some, the pattern only becomes clear after repeated episodes linked to red meat or high-fat dairy, delaying both diagnosis and effective prevention.
The Washington state case report complicates the picture further. If species beyond the lone star tick can sensitize humans to alpha-gal, risk maps based solely on that tick’s range will underestimate who is vulnerable. Researchers are now examining whether other hard ticks in the western United States carry alpha-gal in their saliva or acquire it from feeding on certain mammalian hosts. Until those ecological details are clarified, public health officials face uncertainty about how far north and west AGS risk may extend and whether changing climate or land use is accelerating that spread.
Even within known endemic areas, the relationship between sensitization and disease is murky. The blood-donor data show that in some counties, more than a quarter of adults have detectable IgE to alpha-gal, yet only a fraction seek care for obvious food reactions. Some may have low-level antibodies that never translate into symptoms, while others could be experiencing subtle or intermittent problems-such as nighttime hives or gastrointestinal upset-that they do not connect to previous tick bites or to meals containing mammalian fat.
Living with an allergy that hides in plain sight
For people with confirmed AGS, management hinges on strict avoidance of mammalian meat and, for many, high-fat dairy and organ meats. Because alpha-gal is a sugar, not a protein, it can lurk in gelatin, certain medications derived from animal products, and even some medical devices. Patients are often advised to carry epinephrine auto-injectors and to discuss their diagnosis with surgeons, anesthesiologists, and dentists, who may use products containing bovine or porcine components.
Prevention, however, remains focused on the humble tick bite. Health authorities recommend using repellents, wearing long sleeves and pants in brushy or wooded areas, and performing thorough tick checks after time outdoors. Removing attached ticks promptly may reduce the chance of sensitization, though the exact exposure threshold is unknown. As awareness of AGS grows, some clinicians in high-prevalence regions are beginning to counsel patients who spend significant time outdoors about both Lyme disease and alpha-gal, reflecting a broader shift in how tick-borne risks are framed.
The emerging evidence from surveillance, blood-donor studies, and case reports points to a syndrome that is more widespread, more complex, and more easily overlooked than early descriptions suggested. With sensitization rates in some states approaching one in three adults and documented cases now appearing far from the Southeast, public health agencies face pressure to refine diagnostic criteria, expand education for frontline providers, and deepen research into the ticks and ecological conditions that drive alpha-gal exposure. For now, the combination of delayed reactions, patchy testing, and evolving geography means AGS will likely continue to hide in plain sight, turning familiar foods into unexpected threats for a growing number of Americans.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
